# CRC Detection Reliable Assessment With Blood

> **NCT05551052** · — · ACTIVE_NOT_RECRUITING · sponsor: **New Day Diagnostics** · enrollment: 196 (actual)

## Conditions studied

- Colorectal Cancer
- Adenomas Colon
- Colon Cancer
- Rectal Cancer
- Colon Neoplasm
- Colon Lesion
- Colon Disease
- Colon Polyp
- Polyps
- Adenoma
- Rectal Diseases
- Rectal Polyp
- Gastrointestinal Neoplasms
- Intestinal Neoplasms
- Colonic Diseases, Functional
- Intestinal Disease

## Interventions

- **DIAGNOSTIC_TEST:** Next-Gen CRC Screening Test

## Key facts

- **NCT ID:** NCT05551052
- **Lead sponsor:** New Day Diagnostics
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-09-08
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05551052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05551052, "CRC Detection Reliable Assessment With Blood". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05551052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*